Microfluidic Cartridge Void Space Prevents Channel Deformation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Microfluidic devices for cell purification in CAR T cell therapy face challenges such as biological debris deposition, leading to slower processing and poorer purification efficiency, necessitating improved devices and methods for faster and more effective material purification.
Innovation Solution
The development of microfluidic cartridges with embedded channels and obstacles, featuring a void space configuration to prevent damage and deformation, allowing for size-based separation and fluid flow management to enhance purification efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If microfluidic devices are used for cell purification, then processing speed is improved, but biological debris deposition occurs leading to slower processing and poorer purification efficiency
Solution Approach 1:
The device is divided into multiple parallel channels, each with its own obstacle array. This segmentation allows continuous processing of large volumes while preventing debris accumulation from blocking the entire system, as each channel operates independently. The segmentation maintains high productivity while ensuring reliable purification by distributing flow across multiple paths.
Solution Approach 2:
The obstacle arrays are pre-configured with specific geometries and spacing to create size-based separation zones before the actual purification process begins. The channels are designed with predetermined flow characteristics that guide cells and debris into appropriate separation zones, ensuring efficient purification from the start of processing without requiring intermediate adjustments.
2Manufacturing precision
If delicate features such as posts or obstacles are manufactured in microfluidic devices, then size-based separation capability is improved, but manufacturing complexity increases
Solution Approach 1:
The obstacle arrays are fabricated as thin planar structures with uniform thickness, allowing them to be manufactured using standard photolithography and etching techniques. This approach creates delicate posts and obstacles with precise dimensions while avoiding the need for complex three-dimensional manufacturing processes. The thin-film nature of the obstacles reduces manufacturing complexity while maintaining size-based separation capability.
Solution Approach 2:
The obstacle geometry parameters (height, width, spacing, arrangement patterns) are systematically varied to achieve different separation characteristics for various cell types. By changing these parameters rather than redesigning the entire structure, the device can be manufactured with standard processes while achieving precise size-based separation for different applications.
3Productivity
If multiple lanes or channels are used in a cartridge, then processing throughput is improved, but unwanted mixing and turbulent flow occur
Solution Approach 1:
Physical barriers and channel walls act as intermediaries between adjacent lanes, preventing direct mixing of samples while allowing parallel processing. The channel design includes defined boundaries and separation structures that maintain laminar flow in each lane independently, enabling high throughput without compromising flow stability or causing turbulent mixing between channels.
Solution Approach 2:
The flow path is segmented into multiple independent parallel channels with distinct boundaries. Each channel processes sample independently with controlled flow characteristics, allowing the system to achieve high throughput through parallelization while maintaining stable laminar flow conditions in each segment without interference from adjacent channels.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microfluidic cartridges effectively separate target cells from contaminants, achieving high purity and throughput, enabling efficient processing of biological materials for CAR T cell therapy.
Implementation Method 1
the at least one embedded channel comprising a plurality of obstacles
Implementation Method 2
the at least one void space configured to be deformed when assembling the first and second planar supports into the microfluidic cartridge
Data Source
AI summary
Described herein is a microfluidic cartridge for purifying target particles or target cells of a predetermined size from contaminants in a sample, the cartridge comprising a first and a second planar support the first and second planar support each having a top surface and a bottom surface, wherein the top surface of the first and/or second planar support comprises at least one embedded channel extending from one or more inlets to one or more outlets; the at least one embedded channel comprising a plurality of obstacles, wherein the microfluidic cartridge comprises at least one void space configured to be deformed when assembling the first and second planar supports into the microfluidic cartridge.


